Jamaica, NY, March 08, 2014 --(PR.com
)-- Wimbledon Health Partners, a national provider of Vascular Centers of America (VCOA) and NeuroRad Diagnostic Centers (NDC) announced the opening of a new, state-of-the-art electrodiagnostic and vascular testing center at JFK Medport, in cooperation with Dr. Gerald Surya M.D. Wimbledon Health Partners enables a national network of physician practices to provide precision, on-site diagnostic testing services.
Dr. Surya, a physician serving patients in Jamaica, New York and surrounding area, has recently affiliated with Wimbledon Health Partners to provide both electrodiagnostic and vascular testing. "The support system that Wimbledon Health Partners has to offer practitioners is great. I am eager to put these new tools to use," stated Dr. Surya. The doctor will remain on-site to monitor the quality of testing services.
Dr. Surya and VCOA will be working towards their combined mission to take down the #1 and #3 killers of Americans. The Centers for Disease Control and Prevention (CDC) recognizes cardiovascular disease and cerebrovascular disease as the leading preventable killers of Americans. Currently, diagnostic testing and ultrasound technology is still one of the most effective and noninvasive ways of looking inside your arteries to identify health problems your doctor may not see, before symptoms even show.
Additionally, people who suffer from symptoms such as neck pain, weakness or numbness in the extremities, radiating pain, and lower back pain often can benefit from diagnostic testing to determine the cause of discomfort. Physicians use this information to locate and help alleviate interference with the body’s natural state of being healthy. Having NDC’s diagnostic testing center on-site offers individuals who suffer from pain an easily accessible resource for accurately diagnosing illnesses or injuries that may have gone untreated.
About Wimbledon Health Partners:
Wimbledon Health Partners, a national on-site diagnostic testing organization with capabilities for diagnosing circulatory conditions that can be detected through the use of vascular ultrasound. Furthering their capabilities, nerve conduction velocity testing (NCV) is also utilized to support diagnosis of nerve involvement and manage risk. Wimbledon Health Partners is an innovative cooperative marketing and practice-enhancement program that provides physicians with the educational, compliance, and marketing tools necessary to provide quality, state-of-the-art, in-office testing procedures. For more information go to www.dxtesting.com or call 855-200-VCOA (8262).